XIST was specifically expressed in female GIST patients and was dramatically down-regulated in G3/G4 subtypes, which suggested XIST was significantly inhibited during tumor progression and it seemed to have a protective effect in female GIST patients. This evidence concerns the gene XIST and neoplasm.